Answers are grounded in this paper and cite their sources.
Moringa leaves flavonoid have potential to inhibit α-glucosidase but they have low bioavailability, so they aremade in nanoparticles. It is also not known which specific flavonoid compounds from Moringa leaves have thepotential to inhibit α-glucosidase. This research aimed to determine the inhibition potential of α-glucosidase bythe moringa leaves flavonoid in silico through molecular docking and determine the inhibitory activity of α-glucosidase by moringa leaves flavonoid in extracts and nanoparticles in vitro. Moringa leaves flavonoid havepotential to be a competitive inhibiton of α-glucosidase with the highest to lowest inhibitory potential arecryptochlorogenic acid, quercetin-3-O-beta-D-glucopyranoside, quercetin-3-glucoside, kaempferol-3-O-a-ramnoside, kaempferol-3-O-glucoside, epicathechins, catechins, quercetin, kaempferol, glucomoringinisothiocyanate. Cryptochlorogenic acid has the best potential with ΔG and Ki values -8.5 kcal/mol and 0.5788μM. Inhibition α-glucosidase moringa leaves flavonoid in extract and nanoparticles respectively are classified asinactive (IC 50 = 5.84x10 3 ppm) and active (IC 50 = 1.59x10 1 ppm) in vitro, so nanoparticles can increase theinhibitory activity.
No takes yet. Share an insight, caveat, or question.
Alimah et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: